Cite
Studies from West German Study Group Have Provided New Information about Breast Cancer (Endocrine Therapy Response and 21-gene Expression Assay for Therapy Guidance In Hr+/hp2-early Breast Cancer)
MLA
“Studies from West German Study Group Have Provided New Information about Breast Cancer (Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance In Hr+/Hp2-Early Breast Cancer).” Women’s Health Weekly, Sept. 2022, p. 6219. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.716124244&authtype=sso&custid=ns315887.
APA
Studies from West German Study Group Have Provided New Information about Breast Cancer (Endocrine Therapy Response and 21-gene Expression Assay for Therapy Guidance In Hr+/hp2-early Breast Cancer). (2022, September 8). Women’s Health Weekly, 6219.
Chicago
Women’s Health Weekly. 2022. “Studies from West German Study Group Have Provided New Information about Breast Cancer (Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance In Hr+/Hp2-Early Breast Cancer),” September 8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.716124244&authtype=sso&custid=ns315887.